Lung Cancer ESMO 2024 Highlights

home / data-dialogue-with-the-oncology-brothers / lung-cancer-esmo-2024-highlights

With Stephen Liu, MD, the Oncology Brothers review 4 major studies highlighted at the European Society for Medical Oncology (ESMO) Congress 2024, including the LAURA study, the MARIPOSA and MARIPOSA-2 studies, and the ADRIATIC study.

EP. 1: Overview of the LAURA Study

Rahul Gosain, MD;Rohit Gosain, MD;Stephen Liu, MD

October 17th 2024

Panelists give an overview of the LAURA trial, highlighting its objectives, methodologies, and key findings related to chronic spontaneous urticaria management.

EP. 2: Overview of the MARIPOSA Study

Rahul Gosain, MD;Rohit Gosain, MD;Stephen Liu, MD

October 17th 2024

Panelists provide an overview of the MARIPOSA trial, focusing on its aims, design, and significant results in the context of chronic spontaneous urticaria treatment.

EP. 3: Overview of the ADRIATIC Study

Rahul Gosain, MD;Rohit Gosain, MD;Stephen Liu, MD

October 17th 2024

Panelists provide an overview of the ADRIATIC study, highlighting its objectives, design, and significant results in the context of chronic spontaneous urticaria management.

EP. 4: Overview of the MARIPOSA-2 Study

Rahul Gosain, MD;Rohit Gosain, MD;Stephen Liu, MD

October 17th 2024

Panelists give an overview of the MARIPOSA-2 trial, detailing its objectives, study design, and notable outcomes related to chronic spontaneous urticaria management.